NCT02601729View on ClinicalTrials.gov

Reimbursement Study of Continuous Glucose Monitoring in Belgium

CompletedOBSERVATIONAL

Enrollment

589

Participants

Timeline

Start Date

September 30, 2014

Primary Completion Date

January 18, 2019

Study Completion Date

January 18, 2019

Conditions

Diabetes, Type 1

All Listed Sponsors

lead

KU Leuven

OTHER

NCT02601729 - Reimbursement Study of Continuous Glucose Monitoring in Belgium | Biotech Hunter | Biotech Hunter